Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma.


Journal

Leukemia research
ISSN: 1873-5835
Titre abrégé: Leuk Res
Pays: England
ID NLM: 7706787

Informations de publication

Date de publication:
08 2021
Historique:
received: 17 03 2021
revised: 11 04 2021
accepted: 15 04 2021
pubmed: 4 6 2021
medline: 31 8 2021
entrez: 3 6 2021
Statut: ppublish

Résumé

The aim of this study is to determine the power of he international prognostic scoring systems (IPS-7 and IPS-3) and to obtain indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) factors as prognostic indicators in cases with classical Hodgkin lymphoma (cHL). 1012 patients with cHL were evaluated with 2 different IPS-4 scores with four parameters: stage, age, hemoglobin level, and either LLR or PNI. Statistical package SPSS v 22.0 was used. Two different Cox regression models were obtained for OS and PFS. Model 1 showed LLR ≥ 5,8 as the highest risk for OS and anemia as the highest risk for PFS. Model 2 showed PNI ≤ 45,2 as the highest risk for OS and anemia as the highest risk for PFS. IPS-4 scores obtained by integrating either LLR or PNI to IPS-3 integration of a biologic parameter either LLR or PNI need to be determined with clinical risk scoring parameters.

Identifiants

pubmed: 34082249
pii: S0145-2126(21)00087-4
doi: 10.1016/j.leukres.2021.106586
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106586

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Semra Paydas (S)

Cukurova University, Faculty of Medicine, Dept of Oncology, Turkey; Cukurova University, Faculty of Medicine, Dept of Hematology, Turkey. Electronic address: sepay@cu.edu.tr.

Sahin Lacin (S)

Hacettepe University, Faculty of Medicine, Dept of Oncology, Turkey.

Mutlu Dogan (M)

Ankara Numune Hospital, Dept of Oncology, Turkey.

Ibrahim Barista (I)

Hacettepe University, Faculty of Medicine, Dept of Oncology, Turkey.

Birol Yildiz (B)

Gulhane Hospital, Dept of Oncology, Turkey.

Gulsah Seydaoglu (G)

Cukurova University, Faculty of Medicine, Dept of Biostatistics, Turkey.

Nuri Karadurmus (N)

Gulhane Hospital, Dept of Oncology, Turkey.

Sinem Civriz (S)

Ankara University, Faculty of Medicine, Dept of Hematology, Turkey.

Muhammed Ali Kaplan (MA)

Dicle University, Faculty of Medicine, Dept of Oncology, Turkey.

Munci Yagci (M)

Gazi University, Faculty of Medicine, Dept of Hematology, Turkey.

Huseyin Derya Dincyurek (HD)

Cukurova University, Faculty of Medicine, Dept of Hematology, Turkey.

Vehbi Ercolak (V)

Cukurova University, Faculty of Medicine, Dept of Oncology, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH